ZA926029B - Sulfated glycosaminoglycanoid derivatives. - Google Patents

Sulfated glycosaminoglycanoid derivatives.

Info

Publication number
ZA926029B
ZA926029B ZA926029A ZA926029A ZA926029B ZA 926029 B ZA926029 B ZA 926029B ZA 926029 A ZA926029 A ZA 926029A ZA 926029 A ZA926029 A ZA 926029A ZA 926029 B ZA926029 B ZA 926029B
Authority
ZA
South Africa
Prior art keywords
sulfate
groups
oalk
replaced
functional
Prior art date
Application number
ZA926029A
Other languages
English (en)
Inventor
Maurice Petitou
Boeckel Constant Adriaan An Van
Original Assignee
Akzo Nv
Sanofi Elf
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nv, Sanofi Elf filed Critical Akzo Nv
Publication of ZA926029B publication Critical patent/ZA926029B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H11/00—Compounds containing saccharide radicals esterified by inorganic acids; Metal salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02—Acyclic radicals, not substituted by cyclic structures
    • C07H15/04—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02—Acyclic radicals, not substituted by cyclic structures
    • C07H15/04—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
    • C07H15/08—Polyoxyalkylene derivatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/26—Acyclic or carbocyclic radicals, substituted by hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
ZA926029A 1991-08-23 1992-08-11 Sulfated glycosaminoglycanoid derivatives. ZA926029B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP91402299 1991-08-23

Publications (1)

Publication Number Publication Date
ZA926029B true ZA926029B (en) 1993-03-10

Family

ID=8208605

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA926029A ZA926029B (en) 1991-08-23 1992-08-11 Sulfated glycosaminoglycanoid derivatives.

Country Status (19)

Country Link
EP (1) EP0529715B1 (fi)
JP (1) JP3048198B2 (fi)
KR (1) KR100274115B1 (fi)
AT (1) ATE149504T1 (fi)
AU (1) AU656610B2 (fi)
BR (1) BR1100632A (fi)
CA (1) CA2076063C (fi)
DE (1) DE69217774T2 (fi)
DK (1) DK0529715T3 (fi)
ES (1) ES2101026T3 (fi)
FI (1) FI111726B (fi)
GR (1) GR3023580T3 (fi)
HK (1) HK1002032A1 (fi)
HU (2) HUT62594A (fi)
IL (1) IL102758A (fi)
NO (1) NO179452C (fi)
NZ (1) NZ244057A (fi)
TW (1) TW213470B (fi)
ZA (1) ZA926029B (fi)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69418322D1 (de) * 1993-03-01 1999-06-10 Glycan Pharm Inc Analoge für spezifische oligosaccharid-protein-wechselwirkungen und ihre verwendungen
FR2704226B1 (fr) * 1993-04-22 1995-07-21 Sanofi Elf 3-desoxy oligosaccharides, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent.
IL120722A (en) * 1996-05-08 1999-07-14 Akzo Nobel Nv Polysulfated tetrasaccharide derivatives and pharmaceutical compositions containing them
FR2751334B1 (fr) 1996-07-19 1998-10-16 Sanofi Sa Polysaccharides synthetiques, procede pour leur preparation et compositions pharmaceutiques les contenant
IL126893A (en) * 1997-11-19 2003-05-29 Akzo Nobel Nv Sulfated pentasaccharide derivatives and pharmaceutical compositions containing them
FR2773801B1 (fr) * 1998-01-19 2000-05-12 Sanofi Sa Nouveaux pentasaccharides, procedes pour leurs preparations et compositions pharmaceutiques les contenant
US6083933A (en) * 1999-04-19 2000-07-04 Stellar International Inc. Treatment of cystitis-like symptoms with chondroitin sulfate following administration of a challenge solution
FR2814463B1 (fr) * 2000-09-22 2002-11-15 Sanofi Synthelabo Nouveaux polysaccharides a activite antithrombotique comprenant au moins une liaison covalente avec la biotine ou un derive de la biotine
EP1353556A4 (en) 2001-01-23 2009-09-09 Massachusetts Inst Technology SYNTHESIS OF HEPARIN AND OTHER GLYCOSAMINOGLYCANS IN SOLID PHASE AND SOLUTION PHASE
US7479502B2 (en) 2002-12-03 2009-01-20 Pharmacyclics, Inc. 2-(2-hydroxybiphenyl-3-yl)-1H-benzoimidazole-5-carboxamidine derivatives as factor VIIA inhibitors
US20040161476A1 (en) 2003-02-19 2004-08-19 Hahn Sungtack Samuel Cystitis treatment with high dose chondroitin sulfate
SI1778709T1 (sl) 2004-08-05 2008-12-31 Ivax Drug Res Inst Ltd Polisulfatirani glikozidi in njihove soli
FR2874924B1 (fr) 2004-09-09 2006-12-01 Sanofi Aventis Sa Hexadecasaccharides biotinyles, leur preparation et leur utilisation therapeutique
TWI403334B (zh) 2004-12-23 2013-08-01 Merck Sharp & Dohme 包含生物素殘基之抗血栓雙重抑制劑
TWI376234B (en) 2005-02-01 2012-11-11 Msd Oss Bv Conjugates of a polypeptide and an oligosaccharide
WO2009155108A1 (en) 2008-05-30 2009-12-23 Momenta Pharmaceuticals, Inc. Saccharide structures and methods of making and using such structures
FR2938541B1 (fr) * 2008-11-20 2011-08-26 Sanofi Aventis Pentasaccharide cristallise,son procede d'obtention et son utilisation pour la preparation d'idraparinux
FR2949114B1 (fr) 2009-08-14 2011-08-26 Sanofi Aventis OCTASACCHARIDES N-ACYLES ACTIVATEURS DES RECEPTEURS DES FGFs, LEUR PREPARATION ET LEUR APPLICATION EN THERAPEUTIQUE
FR2949115B1 (fr) 2009-08-14 2012-11-02 Sanofi Aventis OLIGOSACCHARIDES N-SULFATES ACTIVATEURS DES RECEPTEURS DES FGFs, LEUR PREPARATION ET LEUR APPLICATION EN THERAPEUTIQUE
WO2012042123A1 (fr) 2010-09-10 2012-04-05 Sanofi Polysaccharides biotinyles a activite antithrombotique et presentant une stabilite metabolique amelioree
FR2970969B1 (fr) 2011-01-27 2013-10-18 Sanofi Aventis Oligosaccharides 3-o-alkyles activateurs des recepteurs des fgfs, leur preparation et leur application en therapeutique
EP2578594A1 (en) 2011-10-04 2013-04-10 Sanofi Process of preparation of L-iduronic acid comprising a decarboxylation/intramolecular cyclisation tandem reaction
AU2022365434A1 (en) * 2021-10-14 2024-05-02 Owlstone Medical Limited Method for the synthesis of evoc probes

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3017407A (en) * 1958-08-18 1962-01-16 Riker Laboratories Inc Process for producing polysulfuric acid esters of polysaccharides
GB1110939A (en) * 1965-10-06 1968-04-24 Meito Sangyo Kk Sulphuric acid esters of disaccharides and hexitols,and their use as antipeptic ulcer agents
HU172937B (hu) * 1975-12-18 1979-01-28 Chinoin Gyogyszer Es Vegyeszet Sposob poluchenija novykh proizvodnykh khondroitin-sernoj kisloty s mestno anestezirujuhhim ehffektom
US4818816A (en) * 1981-04-28 1989-04-04 Choay, S.A. Process for the organic synthesis of oligosaccharides and derivatives thereof
FR2543145B1 (fr) * 1983-03-24 1986-10-17 Sanofi Sa Nouveaux sulfates de xylanes, leur procede de preparation et leur activite anti-thrombotique et hypolipemiante
AU607690B2 (en) * 1985-12-24 1991-03-14 Marion Laboratories, Inc. Use of synthetic sulfated saccharides to enhance wound healing
EP0300099A1 (en) * 1987-07-20 1989-01-25 Akzo N.V. New pentasaccharides
ES2060284T3 (es) * 1990-04-23 1994-11-16 Sanofi Elf Un procedimiento para la preparacion de un derivado de carbohidrato que comprende una unidad de trisacarido.
EP2301618B1 (en) * 2009-09-23 2011-12-07 Covidien AG A dilation device for dilating an opening

Also Published As

Publication number Publication date
HU211738A9 (en) 1995-12-28
NO923297D0 (no) 1992-08-21
NO179452C (no) 1996-10-09
CA2076063A1 (en) 1993-02-24
HK1002032A1 (en) 1998-07-24
DE69217774D1 (de) 1997-04-10
ATE149504T1 (de) 1997-03-15
DE69217774T2 (de) 1997-06-26
EP0529715B1 (en) 1997-03-05
JPH05194602A (ja) 1993-08-03
FI111726B (fi) 2003-09-15
KR930004324A (ko) 1993-03-22
KR100274115B1 (ko) 2000-12-15
NZ244057A (en) 1995-05-26
TW213470B (fi) 1993-09-21
AU656610B2 (en) 1995-02-09
FI923726A0 (fi) 1992-08-19
CA2076063C (en) 2003-12-30
ES2101026T3 (es) 1997-07-01
AU2121892A (en) 1993-02-25
DK0529715T3 (da) 1997-09-08
FI923726A (fi) 1993-02-24
NO179452B (no) 1996-07-01
JP3048198B2 (ja) 2000-06-05
HUT62594A (en) 1993-05-28
GR3023580T3 (en) 1997-08-29
EP0529715A1 (en) 1993-03-03
BR1100632A (pt) 2000-06-13
IL102758A0 (en) 1993-01-31
NO923297L (no) 1993-02-24
IL102758A (en) 1997-03-18

Similar Documents

Publication Publication Date Title
ZA926029B (en) Sulfated glycosaminoglycanoid derivatives.
AU629315B2 (en) 8-substituted xanthines and their use as pharmaceuticals
IL115746A0 (en) Polyanionic benzylglycosides and pharmaceutical compositions containing them
AU1639888A (en) Novel oxetanocins
MD960212A (en) Acylfulvene analogs as antitumor remedy
GR3021182T3 (en) New peptide compound and a process for the preparation thereof
ES8300768A1 (es) "procedimiento para la preparacion de nuevas pirimido (5,4-d) pirimidinas trisustituidas".
NZ213222A (en) 2-(3,5-dialkyl-4-hydroxyphenyl)-indole derivatives and pharmaceutical compositions
AU8460791A (en) Compound, preparation and use
ES516362A0 (es) "procedimiento para la preparacion de un oligomero de un disocianato alifatico".
ES8203917A1 (es) Un procedimiento para la preparacion de un derivado de nu- cleosido de adenina
IL76652A0 (en) Thiadiazole derivatives,their preparation and pharmaceutical compositions containing them
FR2533561B1 (fr) Procede de preparation des carbamates vinyliques et nouveaux carbamates vinyliques
ZA846783B (en) Nitrosourea derivatives,process for their preparation and pharmaceuticals containing them
KR890009916A (ko) 랩단 유도체, 이의 제조 방법 및 이의 약제로서의 용도
KR910011885A (ko) 면역 활성 및 항종양 활성이 있는 리피드 a동족체